Company / Operating Cash Flow
Mirum Pharmaceuticals, Inc. Operating Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$55.8M
FY2025
5-year range
-$132.8M / $55.8M
FY2021-FY2025
Trend
+440.7%
vs FY2024
Sector context
#58 of 216
Health Care
What the data says
Operating Cash Flow changed +441% YoY in FY2025, a notable deviation from the 7-year average annual change of -1432%.
Based on SEC 10-K filings.
$56M in FY2025.
Improved from -$71M to $56M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#58 of 216 in Health CareTop 27% of 216This company $55.8M Sector average $659.0M
▼
-91.5% below sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s operating cash flow has grown for 3 consecutive years.
- In FY2025, operating cash flow increased 440.7% year-over-year.
- Ranks #58 out of 216 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $55.8M | +440.7% |
| FY2024 | $10.3M | +114.6% |
| FY2023 | -$70.9M | +46.6% |
| FY2022 | -$132.8M | -49.0% |
| FY2021 | -$89.1M | +0.0% |
| FY2020 | -$89.1M | -126.3% |
| FY2019 | -$39.4M | -10452.8% |
| FY2018 | -$373.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026